Tag: Cancer: Leukemia
Radon Exposure Tied to Higher Risk for Childhood Leukemia
Findings seen even for exposure below the U.S. Environmental Protection Agency guidelines
Measurable Residual Disease Results After Consolidation Therapy Predictive of Relapse in Pediatric Leukemia
Patients who are measurable residual disease-negative at end of first consolidation do not need subsequent MRD measurements
High Health Care Utilization, Poor Survival Seen for Over 70s With AML
Of patients who died during observation, median of 56 percent of time between diagnosis and death spent in hospital
Pharmacogenomic Score Can Personalize Treatment of Leukemia in Children
Patients in low ACS10 score group have significantly improved survival with clofarabine+cytarabine treatment
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
Improved overall survival and three-year relapse-free survival seen with blinatumomab plus chemo for adult patients
German Patient is 7th Person Probably Cured of HIV
Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous
Most common ocular manifestations are retinal hemorrhage and Roth spots
Immunoglobulin Replacement Therapy Beneficial for Blood Cancers
Reduction seen in hypogammaglobulinemia, infections or severe infections, and associated antimicrobial use
Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia
PTCy GVHD prophylaxis after allogeneic stem cell transplant yields comparable relapse incidence, lower GVHD
Improved Outcomes Seen With Ibrutinib in Chronic Lymphocytic Leukemia
Time to next treatment was improved for first-line ibrutinib versus chemoimmunotherapy in match-adjusted analyses
